orai1 coding sequences (Addgene inc)
Structured Review

Orai1 Coding Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 35 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/orai1 coding sequences/product/Addgene inc
Average 93 stars, based on 35 article reviews
Images
1) Product Images from "Microscopic analysis of Orai-mediated store-operated calcium entry in cells with experimentally altered levels of amyloid precursor protein."
Article Title: Microscopic analysis of Orai-mediated store-operated calcium entry in cells with experimentally altered levels of amyloid precursor protein.
Journal: Biochemical and biophysical research communications
doi: 10.1016/j.bbrc.2016.08.072
Figure Legend Snippet: Fig. 1. Generation of Jurkat cell lines stably producing APP. (A) Immunoblot of endogenous APP in Jurkat, 293T/17, and HeLa cells carrying APP-targeting shRNA (APP KD) or control shRNA. (B) qPCR analysis of relative APP mRNA levels in cells presented in (A). Differences from the reference level of 1 set for HeLa control cells were analyzed using one-sample t-test (n ¼ 4 each). Significant differences are marked with asterisks (***p < 0.001). (C) Immunoblot of APP, Orai1, and STIM1 in Jurkat cells stably expressing APP, APPSWE or an empty cassette (control), compared with wildtype HeLa cells. (D) FACS analysis of Y188-labeled Jurkat APP cells and APPSWE cells. Y188-labeled and mock-labeled 293T/17 cells were analyzed in parallel to set a threshold for Y188- positive cells (horizontal line). The x-axis of both histograms shows the Y188 signal normalized to cell size (FL1-H/FSC) on a logarithmic scale.
Techniques Used: Stable Transfection, Western Blot, shRNA, Control, Expressing, Labeling
Figure Legend Snippet: Fig. 2. Microscopic analysis of SOCE in APP-producing Jurkat cells. (A) SOCE measurements in Fura-4F-loaded Jurkat cells that produced APP (n ¼ 13), APPSWE (n ¼ 12) and control cells with an empty cassette (n ¼ 13). (B) SOCE measurements in Jurkat cells that produced dominant-negative Orai1 (Orai1 DN; n ¼ 5) and control cells (n ¼ 5). Shown are averaged traces from representative experiments and calculated mean values with standard error. Differences from control cells were analyzed using unpaired t-test, and significant dif- ferences are marked with asterisks (***p < 0.001).
Techniques Used: Produced, Control, Dominant Negative Mutation
Figure Legend Snippet: Fig. 3. Analysis of SOCE in Jurkat cells producing C99 fragments. (A) Immunoblot of small APP fragments (detected with Y188 antibody) in Jurkat cells stably expressing APPSWE, C99 cDNA, or an empty cassette (control) compared with wildtype HeLa cells. DAPT treatment (5 mM for 5 h) is indicated below the gels. (B) Immunoblot of APP, Orai1, and STIM1 in Jurkat cells stably expressing C99 cDNA, C99IND cDNA, or an empty cassette (control) compared with wildtype HeLa cells. (C) qPCR analysis of ORAI1 and STIM1 mRNA levels in C99- producing Jurkat cells relative to those in Jurkat control cells. Differences were analyzed using one-sample t-test (n ¼ 3 each). (D) SOCE measurements in Fura-4F-loaded Jurkat C99 cells (n ¼ 11), C99IND cells (n ¼ 11) and control cells (n ¼ 12). Traces are from representative experiments. The data were analyzed using unpaired t-test.
Techniques Used: Western Blot, Stable Transfection, Expressing, Control
Figure Legend Snippet: Fig. 4. Analysis of SOCE in HeLa cells depleted of APP. (A) SOCE measurements in Fura-2-loaded HeLa cells stably expressing APP-targeting shRNA (APP KD; n ¼ 8), ORAI1-targeting shRNA (ORAI1 KD; n ¼ 3) and control shRNA (control; n ¼ 8). The stores were depleted with 20 mM CPA in Ca2þ-free buffer containing 0.5 mM EGTA for 400 s, and SOCE was initiated by the re-addition of 2 mM Ca2þ. Shown are averaged (black) and individual (gray) SOCE traces from representative experiments. The data were analyzed using unpaired t- test, and significant differences from controls are marked with asterisks (***p < 0.001). (B) qPCR analysis of ORAI1 and STIM1 mRNAs in cells presented in (A). Differences from the reference level of 1 set for controls were analyzed using one-sample t-test (n ¼ 3 each). Statistical significance is marked with asterisks (***p < 0.001).
Techniques Used: Stable Transfection, Expressing, shRNA, Control
